erbb4 Deficits in Chandelier Cells of the Medial Prefrontal Cortex Confer Cognitive Dysfunctions: Implications for Schizophrenia

• Published in: Cerebral cortex (New York, N.Y. 1991) Vol. 29; no. 10; pp. 4334 - 4346
• Main Authors: Yang, Jian-Ming, Shen, Chen-Jie, Chen, Xiao-Juan, Kong, Ying, Liu, Yi-Si, Li, Xiao-Wen, Chen, Zhong, Gao, Tian-Ming, Li, Xiao-Ming
• Format: Journal Article
• Language: English
• Published: United States 13-09-2019
• Subjects: development; GABAergic neurons; L-838417; working memory; axonal initial segment
• ISSN: 1047-3211; 1460-2199
• DOI: 10.1093/cercor/bhy316

erbb4 is a known susceptibility gene for schizophrenia. Chandelier cells (ChCs, also known as axo-axonic cells) are a distinct GABAergic interneuron subtype that exclusively target the axonal initial segment, which is the site of pyramidal neuron action potential initiation. ChCs are a source of ErbB4 expression and alterations in ChC-pyramidal neuron connectivity occur in the medial prefrontal cortex (mPFC) of schizophrenic patients and animal models of schizophrenia. However, the contribution of ErbB4 in mPFC ChCs to the pathogenesis of schizophrenia remains unknown. By conditional deletion or knockdown of ErbB4 from mPFC ChCs, we demonstrated that ErbB4 deficits led to impaired ChC-pyramidal neuron connections and cognitive dysfunctions. Furthermore, the cognitive dysfunctions were normalized by L-838417, an agonist of GABAAα2 receptors enriched in the axonal initial segment. Given that cognitive dysfunctions are a core symptom of schizophrenia, our results may provide a new perspective for understanding the etiology of schizophrenia and suggest that GABAAα2 receptors may be potential pharmacological targets for its treatment.